Intravenous Magnesium for Sickle Cell Vasoocclusive Crisis
Status:
Completed
Trial end date:
2014-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the safety and efficacy of intravenous magnesium in
shortening the duration of a pain crisis and to determine the health-related quality of life
and short term outcomes of children treated with intravenous magnesium during an acute pain
crisis.